Blue Zone Wealth Advisors LLC Has $6.24 Million Position in Relx Plc (NYSE:RELX)

Blue Zone Wealth Advisors LLC raised its stake in Relx Plc (NYSE:RELX - Free Report) by 11.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 123,841 shares of the technology company's stock after acquiring an additional 12,303 shares during the quarter. Relx comprises 1.7% of Blue Zone Wealth Advisors LLC's holdings, making the stock its 23rd largest position. Blue Zone Wealth Advisors LLC's holdings in Relx were worth $6,243,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of RELX. Transce3nd LLC acquired a new stake in shares of Relx during the fourth quarter worth $40,000. Sierra Ocean LLC bought a new position in Relx during the fourth quarter worth about $43,000. Brown Brothers Harriman & Co. raised its stake in Relx by 218.5% in the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Private Trust Co. NA boosted its holdings in Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares during the period. Finally, Whipplewood Advisors LLC bought a new stake in Relx in the 4th quarter valued at about $74,000. 15.02% of the stock is owned by institutional investors.

Relx Price Performance

RELX stock traded down $0.03 during mid-day trading on Tuesday, hitting $53.00. The stock had a trading volume of 752,165 shares, compared to its average volume of 730,174. The firm has a fifty day simple moving average of $52.74 and a 200 day simple moving average of $49.85. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a 52 week low of $43.45 and a 52 week high of $56.33. The firm has a market capitalization of $97.83 billion, a P/E ratio of 28.49, a P/E/G ratio of 2.73 and a beta of 0.84.

Wall Street Analyst Weigh In

RELX has been the topic of several recent research reports. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. The Goldman Sachs Group began coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. Wall Street Zen cut Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.